Finland · Delayed Price · Currency is EUR Bioretec Oy Company Description
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide.
The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery.
It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants.
The company was formerly known as BCI Bioabsorbable Concepts Oy. The company was incorporated in 1998 and is headquartered in Tampere, Finland.
| Country | Finland |
| Founded | 1998 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Sarah Van Hellenberg Hubar-Fisher |
Contact Details
Address: Yrittäjänkulma 5 Tampere, 33710 Finland | |
| Phone | 358 2077 89500 |
| Website | bioretec.com |
Stock Details
| Ticker Symbol | BRETEC |
| Exchange | Nasdaq Helsinki |
| Reporting Currency | EUR |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Sarah Van Hellenberg Hubar-Fisher | Chief Executive Officer |
| Anne-Mari Matikainen | Interim Chief Financial Officer |
| Rene Eve | Director of Operations |
| Timo Lehtonen | Chief Technology Officer |
| Rami Ojala | Head of Global Medical Education |